High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.

@article{Shipp1984HighdoseCA,
  title={High-dose cytosine arabinoside. Active agent in treatment of non-Hodgkin's lymphoma.},
  author={Margaret A. Shipp and R C Takvorian and George Peter Canellos},
  journal={The American journal of medicine},
  year={1984},
  volume={77 5},
  pages={845-50}
}
Seventeen extensively pre-treated patients with non-Hodgkin's lymphoma in relapse were treated with high-dose cytosine arabinoside given at a dose of 3 g/m2 on a 12-hour basis for two to eight doses per course. Seventy percent of patients (12 of 17) showed response with this regimen, including three patients who achieved a complete response. The time to… CONTINUE READING